These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 10028046

  • 21. Effect of acetylcholinesterase oxime-type reactivators K-48 and HI-6 on human liver microsomal cytochromes P450 in vitro.
    Veinlichova A, Jancova P, Siller M, Anzenbacher P, Kuca K, Jun D, Fusek J, Anzenbacherova E.
    Chem Biol Interact; 2009 Aug 14; 180(3):449-53. PubMed ID: 19539805
    [Abstract] [Full Text] [Related]

  • 22. Studies on the cytochrome P450 (CYP)-mediated metabolic properties of miocamycin: evaluation of the possibility of a metabolic intermediate complex formation with CYP, and identification of the human CYP isoforms.
    Kasahara M, Suzuki H, Komiya I.
    Drug Metab Dispos; 2000 Apr 14; 28(4):409-17. PubMed ID: 10725309
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Challenges in exploring the cytochrome P450 system as a source of variation in canine drug pharmacokinetics.
    Martinez MN, Antonovic L, Court M, Dacasto M, Fink-Gremmels J, Kukanich B, Locuson C, Mealey K, Myers MJ, Trepanier L.
    Drug Metab Rev; 2013 May 14; 45(2):218-30. PubMed ID: 23432217
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Azole antimycotics and drug interactions in the perioperative period.
    Saari TI, Olkkola KT.
    Curr Opin Anaesthesiol; 2010 Aug 14; 23(4):441-8. PubMed ID: 20610983
    [Abstract] [Full Text] [Related]

  • 39. [Inhibition of cytochromes P-450. Biochemical mechanisms and possible therapeutic consequences. I--Inactivation by formation of reversible complexes].
    Jayyosi Z, Livertoux MH, Batt AM, Siest G.
    J Toxicol Clin Exp; 1991 Aug 14; 11(1):9-30. PubMed ID: 1875300
    [Abstract] [Full Text] [Related]

  • 40. Structure-based ligand design to overcome CYP inhibition in drug discovery projects.
    Brändén G, Sjögren T, Schnecke V, Xue Y.
    Drug Discov Today; 2014 Jul 14; 19(7):905-11. PubMed ID: 24642031
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.